(Q36579191)

English

Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL).

scientific article published on 22 April 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). (English)

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

health care quality

0 references

1 reference

based on heuristic

inferred from title

Grace Clarke Hillyer

object named as

Grace Clarke Hillyer

2

0 references

Lawrence H. Kushi

object named as

Lawrence H Kushi

3

0 references

Christine Ambrosone

7

object named as

Christine B Ambrosone

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dawn L. Hershman

13

object named as

Dawn L Hershman

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Alfred I. Neugut

1

object named as

Alfred I Neugut

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Jeanne S Mandelblatt

9

object named as

Jeanne S Mandelblatt

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

author name string

Lois Lamerato

4

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Nicole Leoce

5

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

S David Nathanson

6

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Dana H Bovbjerg

8

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Carol Magai

10

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Wei-Yann Tsai

11

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Judith S Jacobson

12

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

language of work or name

0 references

publication date

22 April 2012

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

134

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

1

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

419-428

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Breast cancer adjuvant chemotherapy decisions in older women: the role of patient preference and interactions with physicians

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Lack of knowledge of hormone receptor status and use of endocrine therapy in invasive breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Underuse of breast cancer adjuvant treatment: patient knowledge, beliefs, and medical mistrust

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Adjuvant hormonal therapy use among insured, low-income women with breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Explanations for side effect aversion in preventive medical treatment decisions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Patient adherence and persistence with oral anticancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Women's views on chemoprevention of breast cancer: qualitative study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Developing a quality criteria framework for patient decision aids: online international Delphi consensus process

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Missed opportunities: racial disparities in adjuvant breast cancer treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Adherence to tamoxifen over the five-year course

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Adherence beliefs among breast cancer patients taking tamoxifen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Adherence to Medication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Breast cancer survivors accurately reported key treatment and prognostic characteristics

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Doctor-patient communication patterns in breast cancer adjuvant therapy discussions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

9 September 2017

Delays in adjuvant chemotherapy treatment among patients with breast cancer are more likely in African American and Hispanic populations: a national cohort study 2004-2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

30 September 2017

The MOS social support survey

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

30 September 2017

Patients' willingness to enter clinical trials: measuring the association with perceived benefit and preference for decision participation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3561459

28 June 2018

Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: updated findings from NCIC CTG MA.17.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

A randomized trial of letrozole in postmenopausal women after five years of tamoxifen therapy for early-stage breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor--positive breast cancer.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Agreement between self-reported breast cancer treatment and medical records in a population-based Breast Cancer Family Registry

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Breast cancer treatment in older women: impact of the patient-physician interaction

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Beliefs of chronically ill Japanese patients that lead to intentional non-adherence to medication.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-012-2066-9

21 January 2018

Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Age as a predictor of diagnostic and initial treatment intensity in newly diagnosed breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delay of adjuvant chemotherapy initiation following breast cancer surgery among elderly women

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Policy support for patient-centered care: the need for measurable improvements in decision quality

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physicians' reasons for failing to deliver effective breast cancer care: a framework for underuse

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Racial disparities in treatment and survival among women with early-stage breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lost opportunities: physicians' reasons and disparities in breast cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delay in initiating adjuvant radiotherapy following breast conservation surgery and its impact on survival

1 reference

https://pubmed.ncbi.nlm.nih.gov/22527111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10549-012-2066-9

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36579191&oldid=2199053713"